As of 2:14pm ET
| -0.06 / -3.49%|
The 2 analysts offering 12-month price forecasts for Navidea Biopharmaceuticals Inc have a median target of 5.58, with a high estimate of 9.00 and a low estimate of 2.15. The median estimate represents a +235.84% increase from the last price of 1.66.
The current consensus among 2 polled investment analysts is to Buy stock in Navidea Biopharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.